Intercept Pharmaceuticals, Inc.

Tower Research Capital LLC (TRC)

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

1,672

Value ($000)

31

Weight

0.0%

2013 Q4 - 2023 Q3 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	31	0.0%	1,672	9/30/2023
2023 Q2	8/14/2023	141	0.0%	12,712	6/30/2023
2023 Q1	5/9/2023	134	0.0%	9,973	3/31/2023
2022 Q4	2/10/2023	122	0.0%	9,876	12/31/2022
2022 Q3	11/10/2022	521	0.0%	37,372	9/30/2022
2022 Q2	8/15/2022	116	0.0%	8,419	6/30/2022
2022 Q1	5/12/2022	64	0.0%	3,962	3/31/2022
2021 Q4	2/14/2022	123	0.0%	7,538	12/31/2021
2021 Q3	11/15/2021	239	0.0%	16,073	9/30/2021
2021 Q2	8/16/2021	54	0.0%	2,712	6/30/2021
2021 Q1	5/17/2021	52	0.0%	2,251	3/31/2021
2020 Q4	2/16/2021	242	0.0%	9,812	12/31/2020
2020 Q3	11/16/2020	84	0.0%	2,018	9/30/2020
2020 Q2	8/13/2020	189	0.0%	3,956	6/30/2020
2013 Q4	1/31/2014	78	0.0%	1,146	12/31/2013